Foresite Capital Management II’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-2,565
| Closed | -$108K | – | 11 |
|
|
2017
Q3 | $108K | Sell |
2,565
-7,410
| -74% | -$312K | 0.04% | 12 |
|
|
2017
Q2 | $420K | Sell |
9,975
-27,480
| -73% | -$1.16M | 0.19% | 11 |
|
|
2017
Q1 | $2.1M | Sell |
37,455
-17,860
| -32% | -$999K | 0.9% | 10 |
|
|
2016
Q4 | $2.11M | Sell |
55,315
-8,022
| -13% | -$306K | 1.06% | 7 |
|
|
2016
Q3 | $2.52M | Hold |
63,337
| – | – | 1.2% | 8 |
|
|
2016
Q2 | $4.55M | Sell |
63,337
-55,186
| -47% | -$3.97M | 3.11% | 8 |
|
|
2016
Q1 | $9.5M | Sell |
118,523
-5,511
| -4% | -$442K | 4.65% | 10 |
|
|
2015
Q4 | $9.36M | Buy |
124,034
+56,426
| +83% | +$4.26M | 3.14% | 10 |
|
|
2015
Q3 | $25.9M | Hold |
67,608
| – | – | 7.87% | 3 |
|
|
2015
Q2 | $28.1M | Sell |
67,608
-225,013
| -77% | -$93.5M | 9.86% | 4 |
|
|
2015
Q1 | $56.5M | Buy |
292,621
+250,940
| +602% | +$48.4M | 33.47% | 1 |
|
|
2014
Q4 | $15.4M | Buy |
+41,681
| New | +$15.4M | 10.56% | 3 |
|